How I treat... Basal cell carcinoma by imiquimod;Comment je traite.... Un carcinome basocellulaire par l'imiquimod topique (Aldara®)

Revue Medicale de Liege

Volumn 60, Issue 4, 2005, Pages 207-209

  Pierard Franchimont C ^a   Nikkels, A F ^a   Paquet, P ^a   Quatresooz, P ^a   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Basal cell carcinoma; Imiquimod; Immunotherapy

Indexed keywords

IMIQUIMOD;

BASAL CELL CARCINOMA; CANCER SURGERY; FOLLOW UP; HUMAN; IMMUNOTHERAPY; NATURAL KILLER CELL; PROGNOSIS; REMISSION; REVIEW; TUMOR RECURRENCE; TUMOR REGRESSION;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; CARCINOMA, BASAL CELL; HUMANS; SKIN NEOPLASMS;

EID: 19044387331     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Piérard-Franchimont C. et Piérard GE.- Tumeurs cutanées fréquentes en gériatrie. Rev Med Liège, 1997, 52, 289-295.
2. Stern RS.- The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol, 1999, 135, 843-844.
3. Uhoda I, Quatresooz P, Fumal I, et al.- Updating trends in cutaneous cancers in south-east Belgium. Oncol Reports, 2004, 12, 111-114.
4. Holikova Z, Massi D, Lotti T, Hercogova J.- Insight into the pathogenesis of sporadic basal cell carcinoma. Int J Dermatol, 2004, 43, 865-869.
5. MacKie RM.- Awareness, knowledge and attitudes to basal cell carcinoma and actinic keratoses among the general public within Europe. J Eur Acad Dermatol Venereol, 2004, 18, 552-555.
6. Kuijpers DIM, Thissen RTM, Neumann HA.- Basal cell carcinoma. Treatment options and prognosis, a scientific approach to a common malignancy. Am J Clin Dermatol, 2002, 3, 247-259.
7. Beutner KR, Geisse JK, Helman D, et al.- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol, 1999, 41, 1002-1007.
8. Hannuksela-Svahn A, Nordal E, Christiensen OB.- Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream. Acta Derm Venereol, 2000, 80, 381-382.
9. Kagy MK, Amonette R.- The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatol Surg, 2000, 26, 577-578.
10. Marks R, Gebauer K, Shumack S, et al.- Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol, 2001, 44, 807-813.
11. Hermanns-Lê T, Nikkels AF, Uhoda I, et al.- L'imiquimod (Aldara®): un immunomodulateur pour la peau. Rev Med Liège, 2002, 57, 116-118.
12. Micali G, De Pasquale R, Caltabiano R, et al.- Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatol Treat, 2002, 13, 123-127.
13. Shumack S, Robinson J, Kossard S, et al.- Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol, 2002, 138, 1165-1171.
14. Sterry W, Herera E, Takwale A, et al.- Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol, 2002, 147, 1227-1236.
15. Stockfleth E, Ulrich C, Hauschild A, et al.- Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol, 2002, 12, 569-572.
16. Weisberg NK, Varghese M.- Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream. Dermatol Surg, 2002, 28, 518-523.
17. Eklind J, Tartler U, Machke J, et al.- Imiquimod to treat different cancers of the epidermis. Dermatol Surg, 2003, 29, 890-896.
18. Gaspar AA, Spuder DN.- Immunotherapy of basal cell carcinoma: evolving approaches. Dermatol Surg, 2003, 29, 1027-1034.
19. Geisse J, Caro I, Lindholm J et al.- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol, 2004, 50, 722-733.
20. Urosevic M, Dummer R.- Role of imiquimod in skin cancer treatment. Am J Clin Dermatol, 2004, 5, 453-458.
21. Stanley MA.- Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol, 2002, 27, 571-577.
22. Urosevic M, Maier T, Benninghoff B et al.- Mechanisms underlying Imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol, 2003, 139, 1325-1332.
23. Suzuki H, Wang B, Shiviji GM, et al.- Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J Invest Dermatol, 2000, 114, 135-141.
24. Arrese JE, Paquet P, Claessens N, et al.- Dermal dendritic cells in anogenital warty lesions unresponsive to an immune-response modifier. J Cutan Pathol, 2001, 28, 131-134.
25. Hermanns-Lê T, Paquet P, Nikkels AF, et al.- Prolonged imiquimod treatment and graft-versus-host reaction: histological mimicry in the pattern of monocyte macrophage-dendrocyte lineage skin infiltration. Dermatology, 2003, 206, 361-365.
26. Quatresooz P, Piérard GE.- Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes. Clin Exp Dermatol, 2003, 28, S27-S29.
27. Uhoda I, Quatresooz P, Piérard-Franchimont C, Piérard GE.- Nudging epidermal field cancerogenesis by imiquimod. Dermatology, 2003, 206, 357-360.
28. Schön M, Bong AB, Drewniok C et al.- Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst, 2003, 95, 1138-1149.
29. Sullivan TP, Dearaujo T, Vincek V et al.- Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream of vehicle for apoptosis and lymphocyte phenotyping. Dermatol Surg, 2003, 29, 1181-1185.
30. Schön MP, Schön M.- Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis, 2004, 9, 291-298.
31. Bourguignon R, Paquet P, Quatresooz P, Piérard GE.-Comment je traite... un lentigo malin par rimiquimod topique (Aldara®). Rev Med Liège, sous presse.
32. Zitelli JA.- Use of imiquimod for treating skin cancer. J Am Acad Dermatol, 2005, 52, 177.